Daily propranolol prevents prolonged mobilization of hematopoietic progenitor cells in a rat model of lung contusion, hemorrhagic shock, and chronic stress

Surgery. 2015 Sep;158(3):595-601. doi: 10.1016/j.surg.2015.06.031. Epub 2015 Jul 21.

Abstract

Introduction: Propranolol has been shown previously to decrease the mobilization of hematopoietic progenitor cells (HPCs) after acute injury in rodent models; however, this acute injury model does not reflect the prolonged period of critical illness after severe trauma. Using our novel lung contusion/hemorrhagic shock/chronic restraint stress model, we hypothesize that daily administration of propranolol will decrease prolonged mobilization of HPCs without worsening lung healing.

Methods: Male Sprague-Dawley rats underwent 6 days of restraint stress after undergoing lung contusion or lung contusion/hemorrhagic shock. Restraint stress consisted of a daily 2-hour period of restraint interrupted every 30 minutes by alarms and repositioning. Each day after the period of restraint stress, the rats received intraperitoneal propranolol (10 mg/kg). On day 7, peripheral blood was analyzed for granulocyte-colony stimulating factor (G-CSF) and stromal cell-derived factor 1 via enzyme-linked immunosorbent assay and for mobilization of HPCs using c-kit and CD71 flow cytometry. The lungs were examined histologically to grade injury.

Results: Seven days after lung contusion and lung contusion/hemorrhagic shock, the addition of chronic restraint stress significantly increased the mobilization of HPC, which was associated with persistently increased levels of G-CSF and increased lung injury scores. The addition of propranolol to lung contusion/chronic restraint stress and lung contusion/hemorrhagic shock/chronic restraint stress models greatly decreased HPC mobilization and restored G-CSF levels to that of naïve animals without worsening lung injury scores.

Conclusion: The daily administration of propranolol after both lung contusion and lung contusion/hemorrhagic shock subjected to chronic restraint stress decreased the prolonged mobilization of HPC from the bone marrow and decreased plasma G-CSF levels. Despite the decrease in mobilization of HPC, lung healing did not worsen. Alleviating chronic stress with propranolol may be a future therapeutic target to improve healing after severe injury.

Publication types

  • Evaluation Study
  • Research Support, N.I.H., Extramural

MeSH terms

  • Adrenergic beta-Antagonists / pharmacology
  • Adrenergic beta-Antagonists / therapeutic use*
  • Animals
  • Biomarkers / blood
  • Chemokine CXCL12 / blood
  • Contusions / complications
  • Contusions / drug therapy*
  • Drug Administration Schedule
  • Enzyme-Linked Immunosorbent Assay
  • Flow Cytometry
  • Granulocyte Colony-Stimulating Factor / blood
  • Hematopoietic Stem Cells / drug effects*
  • Hematopoietic Stem Cells / physiology
  • Injections, Intraperitoneal
  • Lung Injury / complications
  • Lung Injury / drug therapy*
  • Lung Injury / physiopathology
  • Male
  • Propranolol / pharmacology
  • Propranolol / therapeutic use*
  • Random Allocation
  • Rats
  • Rats, Sprague-Dawley
  • Shock, Hemorrhagic / complications
  • Shock, Hemorrhagic / drug therapy*
  • Shock, Hemorrhagic / physiopathology
  • Stress, Psychological / complications
  • Stress, Psychological / drug therapy*
  • Stress, Psychological / physiopathology
  • Treatment Outcome

Substances

  • Adrenergic beta-Antagonists
  • Biomarkers
  • CXCL12 protein, rat
  • Chemokine CXCL12
  • Granulocyte Colony-Stimulating Factor
  • Propranolol